Trader Plus caught up with former managing director Joseph Taylor to discuss the company’s development of fully integrated vertical sales channels.
Trader Plus talks to Kevin Levine, Rubicor chief executive, about the company’s plans to rebuild in 2015 and beyond.
This year has seen the price of iron ore nearly halve in value. Traders have been anticipating a low in stock prices only to find that they continue to plummet to even lower levels. Higher cost producers such as Atlas Iron (AGO), Arrium (ARI), and BC Iron (BCI) have seen the majority of their market…
Michael Gable, from the Australian Technical Analysts Association, explores the recent performance of Telstra (TLS) through technical analysis.
Craig Dunstan took time out on day one of the Australian Microcap Investment Conference to give a wrap of the first day’s activities.
Bourse Communications managing director Rodney North discusses the microcap sector’s performance in 2014, and the outlook for the Australian stock exchange towards the end of the year.
Trader Plus caught up with Diploma Group managing director Nick Di Latte to discuss the company’s short-term opportunities and achievements to date.
Phosphagenics Limited chief scientific officer Dr Paul Gavin discusses the company’s unique achievements and outlook with Trader Plus.
Biotron Ltd chief executive Dr Michelle Miller discusses the company’s achievements and outlook with Trader Plus.
Chief executive Brad Walsh discusses the opportunities for biotech play Minomic, which is developing a new test for prostate cancer that potentially avoids the need for biopsy in some cases.